Caecal cancer associated with longstanding Crohn's disease

Lancet

Volumn 368, Issue 9549, 2006, Pages 1842-

  Uza, Norimitsu ^a   Nakase, Hiroshi ^a   Kuwabara, Yasuhide ^a   Fujii, Shigehiko ^a   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CECUM CANCER; CLINICAL FEATURE; COLONOSCOPY; CROHN DISEASE; ENDOSCOPY; HEMICOLECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

EID: 33750958547     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69741-9     Document Type: Article

References (5)

1. Choi P., and Zelig M. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35 (1994) 950-954
2. Jess T., Gamborg M., Matzen P., Munkholm P., and Sorensen T. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 100 (2005) 2724-2729
3. Canavan C., Abrams K., and Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 15 (2006) 1097-1104
4. Velayos F., Terdiman J., and Walsh J. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 100 (2005) 1345-1353
5. Munkholm P., Loftus Jr. E., Reinacher-Schick A., Kornbluth A., Mittmann U., and Esendal B. Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates. Digestion 73 (2006) 11-19